Twitter, Inc. (NYSE:TWTR): Hudson Square initiated Twitter with a Sell and $20 price target. The firm said while the multiple is far above its peers, and appears to reflect every upside scenario in its growth outlook, the analyst is concerned it doesn’t focus enough on profits.
Hasbro, Inc. (NYSE:HAS): Piper Jaffray likes shares of Hasbro (NYSE:HAS) into 2014 after Disney (NYSE:DIS) said last night that Star Wars Episode VII will be released in December 2015. Piper says the riming, while later than some had speculated, brings greater scale potential given seasonal demand for toys during the holiday period. Piper says Star Wars related sales will “easily extend” into the first half of 2016 for Hasbro and raised its price target for the stock to $60 from $55.
SunEdison, Inc. (NYSE: SUNE): Citigroup nearly doubled its price target for SunEdison shares to $21 from $11, citing a stronger than expected fundamental outlook, and potential price upside from the pending YieldCo and ABS transaction. The firm keeps a Buy rating on the stock.
ImmunoGen, Inc. (NASDAQ:IMGN): After ImmunoGen discontinued IMGN901 trials and RBC Capital met with the company’s management, the firm still has a positive view of the company’s platform technology, and contends that it has several upcoming positive catalysts. RBC lowered its price target on the shares to $18 from $22, but keeps an Outperform rating.